San Diego, CA, United States of America

Anne L Prieto

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anne L Prieto

Introduction

Anne L Prieto is a notable inventor based in San Diego, CA. He has made significant contributions to the field of neuroscience through his innovative work on cytotactin derivatives. His research focuses on enhancing neuronal attachment and promoting neurite outgrowth, which has important implications for therapeutic applications.

Latest Patents

Anne L Prieto holds a patent for "Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making same." This invention relates to cytotactin proteins, polypeptides, antibodies, and other derivatives that are useful in mediating neuronal attachment and enhancing neurite outgrowth. The patent also discloses methods for producing these proteins and related compositions, which have various diagnostic and therapeutic applications.

Career Highlights

Prieto is affiliated with the Scripps Research Institute, where he has been involved in groundbreaking research. His work has contributed to a better understanding of neuronal behavior and has opened new avenues for treatment strategies in neurodegenerative diseases.

Collaborations

Throughout his career, Anne L Prieto has collaborated with esteemed colleagues, including Kathryn L Crossin and Greg Phillips. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Anne L Prieto's contributions to the field of neuroscience through his innovative patents and collaborative efforts highlight his importance as an inventor. His work continues to influence the development of therapeutic strategies for neurological conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…